Baseline serum levels of cardiac biomarkers in patients with stable coronary artery disease

References

• Ahmed SA, Williamson JR, Roberts R, Clark RE, Sobel BE. The association of increased plasma MB CPK activity and irreversible ischemic myocardial injury in the dog. Circulation 1976; 54: 187–193
   PubMed Web of Science ®Google Scholar
• Apple FS, Murakami M, Panteghini M, Christenson RH, Dati F, Mair J, et al. IFCC Committee on Standardization of Markers of Cardiac Damage. International survey on the use of cardiac markers. Clinical Chemistry 2001; 47: 587–588
   PubMedGoogle Scholar
• Benoit T, Vivegnis D, Foulon J, Rigo P. Quantitative evaluation of myocardial single-photon emission tomographic imaging: application to the measurement of perfusion defect size and severity. European Journal of Nuclear Medicine 1996; 23: 1603–1612
   PubMedGoogle Scholar
• Berman DS, Hachamovitch R, Kiat H, Cohen I, Cabico JA, Wang FP, et al. Incremental value of prognostic testing in patients with known or suspected ischemic heart disease: a basis for optimal utilization of exercise technetium-99m sestamibi myocardial perfusion single-photon emission computed tomography. Journal of the American College of Cardiology 1995; 26: 639–647
   PubMed Web of Science ®Google Scholar
• Cavallini C, Rugolotto M, Savonitto S. Prognostic significance of creatine kinase release after percutaneous coronary intervention. Italian Heart Journal 2005; 6: 522–529
   Google Scholar
• Collinson PO. Cardiac markers into the new millennium. Annals of Clinical Biochemistry 2000; 37: 109–113
   Google Scholar
• Germano G, Kiat H, Kavanagh PB, Moriel M, Mazzanti M, Su HT, et al. Automatic quantification of ejection fraction from gated myocardial perfusion SPECT. Journal of Nuclear Medicine 1995; 36: 2138–2147
   PubMed Web of Science ®Google Scholar
• Heyndrickx GR, Amano J, Kenna T, Fallon JT, Patrick TA, Manders WT, et al. Creatine kinase release not associated with myocardial necrosis after short periods of coronary artery occlusion in conscious baboons. Journal of Molecular & Cell Cardiology 1985; 6: 1299–1303
   Google Scholar
• Ishikawa Y, Saffitz JE, Mealman TL, Grace AM, Roberts R. Reversible myocardial ischemic injury is not associated with increased creatine kinase activity in plasma. Clinical Chemistry 1997; 43: 467–475
   Google Scholar
• Kang X, Van Train K, Lewin HC. Prognostic value of automatic quantitative defect extent, severity and reversibility in exercise myocardial perfusion SPECT: comparison with visual analysis. Journal of Nuclear Medicine 1997; 38: 53P
   Google Scholar
• Maddahi J, Van Train K, Prigent F, Garcia EV, Friedman J, Ostrzega E, et al. Quantitative single photon emission computed thallium-201 tomography for detection and localization of coronary artery disease: optimization and prospective validation of a new technique. Journal of the American College of Cardiology 1989; 14: 1689–1699
   Google Scholar
• Mair J. Tissue release of cardiac markers: from physiology to clinical applications. Clinical Chemistry & Laboratory Medicine 1999; 37: 1077–1084
   PubMed Web of Science ®Google Scholar
• Michael LH, Hunt JR, Weilbaecher D, Perryman MB, Roberts R, Lewis RM, et al. Creatine kinase and phosphorylase in cardiac lymph: coronary occlusion and reperfusion. American Journal of Physiology 1985; 248: 350–359
   Google Scholar
• Panteghini M, Apple FS, Christenson RH, Dati F, Mair J, Wu AH. Use of biochemical markers in acute coronary syndromes. IFCC Scientific Division, Committee on Standardization of Markers of Cardiac Damage. International Federation of Clinical Chemistry. Clinical Chemistry Laboratory Medicine 1999; 37: 687–693
   PubMedGoogle Scholar
• Piper HM, Schwartz P, Spahr R, Hutter JF, Spieckermann PG. Early enzyme release from myocardial cells is not due to irreversible cell damage. Journal of Molecular & Cell Cardiology 1984; 16: 385–388
   PubMed Web of Science ®Google Scholar
• Razek HA, Erler BS, Talley JD. Serial troponin I measurements detect recurrent myocardial infarction after initial acute myocardial infarction. Journal of the Arkansas Medical Society 2000; 97: 202–204
   Google Scholar
• Remppis A, Scheffold T, Greten J, Haass M, Greten T, Kubler W, et al. Intracellular compartmentation of troponin T: release kinetics after global ischemia and calcium paradox in the isolated perfused rat heart. Journal of Molecular & Cell Cardiology 1995; 27: 793–803
   PubMed Web of Science ®Google Scholar
• Roberts R, Fromm RE. Management of acute coronary syndromes based on risk stratification by biochemical markers: an idea whose time has come. Circulation 1998; 98: 1853–1859
   Google Scholar
• Sakai K, Spieckermann PG. Effects of reserpine and propranolol on anoxia-induced enzyme release from the isolated perfused guinea-pig-heart. Naunyn-Schmiedeberg's Archives of Pharmacology 1975; 291: 123–130
   Google Scholar
• Sharir T, Germano G, Waechter PB, Kavanagh PB, Areeda JS, Gerlach J, et al. A new algorithm for the quantitation of myocardial perfusion SPECT. II. Validation and diagnostic yield. Journal of Nuclear Medicine 2000; 41: 720–727
   Google Scholar
• Sorichter S, Mair J, Koller A, Calzolari C, Huonker M, Pau B, et al. Release of muscle proteins after downhill running in male and female subjects. Scandinavian Journal of Medicine & Science in Sports 2001; 11: 28–32
   PubMed Web of Science ®Google Scholar
• Spieckermann PG, Nordbeck H, Preusse CJ. From heart to plasma. Enzymes in Cardiology, Diagnosis and Research, DJ Hearse, J Leiris, D Loisance. John Wiley and Sons, Belfast 1979; 81–95
   Google Scholar
• Taillefer R, Ahlberg AW, Masood Y, White CM, Lamargese I, Mather JF, et al. Acute beta-blockade reduces the extent and severity of myocardial perfusion defects with dipyridamole Tc-99m sestamibi SPECT imaging. Journal of the American College of Cardiology 2003; 42: 1475–1483
   Google Scholar
• Turer AT, Mahaffey KW, Gallup D, Weaver WD, Christenson RH, Every NR, et al. Enzyme estimates of infarct size correlate with functional and clinical outcomes in the setting of ST-segment elevation myocardial infarction. Current Control Trials Cardiovascular Medicine 2005; 23: 6–12
   Google Scholar
• Van Train KF, Areeda J, Garcia EV, Cooke CD, Maddahi J, Kiat H, et al. Quantitative same-day rest-stress technetium-99m-sestamibi SPECT: definition and validation of stress normal limits and criteria for abnormality. Journal of Nuclear Medicine 1993; 34: 1494–1502
   PubMed Web of Science ®Google Scholar
• Voss EM, Sharkey SW, Gernert AE, Murakami MM, Johnston RB, Hsieh CC, et al. Human and canine cardiac troponin T and creatine kinase-MB distribution in normal and diseased myocardium. Infarct sizing using serum profiles. Archives of Pathology & Laboratory Medicine 1995; 119: 799–806
   PubMed Web of Science ®Google Scholar
• Wienen W, Kammermeier H. Intra- and extracellular markers in interstitial transudate of perfused rat hearts. American Journal of Physiology 1988; 254: 785–794
   Google Scholar
• Wiviott SD, Cannon CP, Morrow DA, Murphy SA, Gibson CM, McCabe CH, et al. Differential expression of cardiac biomarkers by gender in patients with unstable angina/non-ST-elevation myocardial infarction: a TACTICS-TIMI 18 (Treat Angina with Aggrastat and determine Cost of Therapy with an Invasive or Conservative Strategy-Thrombolysis In Myocardial Infarction 18) substudy. Circulation 2004; 109: 565–567
   Google Scholar
• Wu AHB. Biochemical markers of cardiac damage: from traditional enzymes to cardiac-specific proteins. Scandinavian Journal of Clinical & Laboratory Investigation 1999; 59(Suppl. 230)74–82
   Google Scholar
• Wu AH, Ford L. Release of cardiac troponin in acute coronary syndromes: ischemia or necrosis?. Clinica Chimica Acta 1999; 284: 161–174
   PubMed Web of Science ®Google Scholar
• Yoshioka J, Hasegawa S, Yamaguchi H, Tokita N, Paul AK, Xiuli M, et al. Left ventricular volumes and ejection fraction calculated from quantitative electrocardiographic-gated 99mTc-teterofosmin myocardial SPECT. Journal of Nuclear Medicine 1999; 40: 1693–1698
   Google Scholar